Search Within

Klaus J Busam

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (11)
  2. Department of Pathology and Laboratory Medicine (11)
  3. Genitourinary Oncology Service (11)
  4. Melanoma Disease Management Team (11)
  5. Solid Tumor Oncology Division (11)
  6. Survivorship Research (8)

More Groups

People
  1. Mario Lacouture (5)
  2. Michael Postow (4)
  3. Robert Motzer (4)
  4. Alexander Shoushtari (3)
  5. Charlotte Ariyan (3)
  6. David Solit (3)

More People

Years
  1. 2021 (2)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (1)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. British Journal of Dermatology (2)
  2. Clinical Cancer Research (2)
  3. Journal of Clinical Oncology (2)
  4. Cancer (1)
  5. Case Reports in Oncology (1)
  6. European Journal of Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. Blackwell Publishing (2)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of metastatic extramammary Paget disease with combination ipilimumab and nivolumab: A case report
    Journal Article

    Guercio, B. J.; Iyer, G.; Kidwai, W. Z.; Lacouture, M. E.; Ghafoor, S.; Rossi, A. M.; Assis, D. N.; Chen, Y. B.; Busam, K. J.; Janjigian, Y. Y.; more...
    Case Reports in Oncology (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of a novel driver classification system for cutaneous and unknown primary melanomas
    Meeting Abstract

    Shoushtari, A. N.; Sanchez-Vega, F.; Kantheti, H.; Callahan, M. K.; Postow, M. A.; Barker, C. A.; Chatila, W. K.; Jonsson, P.; Ariyan, C. E.; Brady, M. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Rates of ERBB2 alterations across melanoma subtypes and a complete response to trastuzumab emtansine in an ERBB2-amplified acral melanoma
    Journal Article

    Gottesdiener, L. S.; O'Connor, S.; Busam, K. J.; Won, H.; Solit, D. B.; Hyman, D. M.; Shoushtari, A. N.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
    Journal Article

    Zarbo, A.; Belum, V. R.; Sibaud, V.; Oudard, S.; Postow, M. A.; Hsieh, J. J.; Motzer, R. J.; Busam, K. J.; Lacouture, M. E.
    British Journal of Dermatology (2017)

    Fulltext@MSK | Save
  • Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
    Journal Article

    Belum, V. R.; Benhuri, B.; Postow, M. A.; Hellmann, M. D.; Lesokhin, A. M.; Segal, N. H.; Motzer, R. J.; Wu, S.; Busam, K. J.; Wolchok, J. D.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
    Journal Article

    Wiesner, T.; Lee, W.; Obenauf, A. C.; Ran, L.; Murali, R.; Zhang, Q.; Wong, E. W. P.; Hu, W.; Scott, S. N.; Shah, R. H.; more...
    Nature (2015)

    Fulltext@MSK | Save
  • Clinical and histologic characterization of dermatologic adverse events front the pan-PI3K inhibitor buparlisib (BKM-120)
    Meeting Abstract

    Schindler, K.; Abraham, R.; Shah, P. D.; Chandarlapaty, S.; Paik, P. K.; Bell-Mcguinn, K.; Bajorin, D. F.; Mellinghoff, I. K.; Younes, A.; Gounder, M. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors
    Journal Article

    Balagula, Y.; Rosen, A.; Tan, B. H.; Busam, K. J.; Pulitzer, M. P.; Motzer, R. J.; Feldman, D. R.; Konner, J. A.; Reidy-Lagunes, D.; Myskowski, P. L.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Violaceous exanthem as a manifestation of metastatic prostate cancer in skin
    Journal Article

    Slovin, S. F.; Galsky, M. D.; Busam, K.
    Urology (2006)

    Fulltext@MSK | Save